Tivic Health Systems, Inc. (TIVC)
$
4.25
-0.10 (-2.35%)
Key metrics
Financial statements
Free cash flow per share
-8.2969
Market cap
4.1 Million
Price to sales ratio
7.9556
Debt to equity
0
Current ratio
1.7018
Income quality
0.8717
Average inventory
312.5 Thousand
ROE
-1.8023
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Tivic Health Systems Inc. operates as a bioelectronic device company, specializing in non-invasive neuromodulation products aimed at treating inflammatory conditions. Its flagship product, ClearUP, is a medical device designed to alleviate sinus and nasal inflammation, which positions the company as an innovative contributor to healthcare solutions. The earnings per share (EPS) is reported at -$19.67 indicating the company's profitability on a per-share basis. Moreover, the net total of other income and expenses is $6,000.00 reflecting non-core financial activities that may influence its financial health. The overall costs and expenses for the company stand at $6,441,000.00 showcasing its total spending, while operating expenses amount to $5,663,000.00 encompassing a range of operational costs incurred during its activities. The operating income ratio is -7.26 providing insight into the company's operational profitability margin, which is crucial for evaluating its financial effectiveness in the market. As a small-cap player with a market capitalization of $4,105,071.00 Tivic Health is considered a notable entity within the industry landscape. The stock is affordable at $4.25 making it suitable for budget-conscious investors seeking to engage with the market. The stock also has a high average trading volume of 671,321.00 indicating strong liquidity, which is essential for investors looking to buy or sell shares without significant price fluctuations. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape and fostering advancements that may benefit consumers. Additionally, it belongs to the Healthcare sector, driving innovation and growth, which underscores its potential impact on the healthcare ecosystem. Through strategic initiatives and consumer outreach via platforms like Amazon.com and Walmart.com, Tivic Health Systems, Inc. continues to expand its market presence and cater to the demands of its customer base.
Is Tivic Health Systems, Inc. (TIVC) a good investment?
Investing in Tivic Health Systems, Inc. (TIVC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Tivic Health Systems, Inc. (TIVC)'s stock forecast?
Analysts predict Tivic Health Systems, Inc. stock to fluctuate between $2.43 (low) and $16.08 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Tivic Health Systems, Inc.'s market capitalization?
As of 2025-07-10, Tivic Health Systems, Inc.'s market cap is $4,105,071, based on 965,899 outstanding shares.
How does Tivic Health Systems, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Tivic Health Systems, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Tivic Health Systems, Inc. (TIVC) stock?
To buy Tivic Health Systems, Inc. (TIVC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for TIVC. Place an order (Market, Limit, etc.).
What is the best time to invest in Tivic Health Systems, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Tivic Health Systems, Inc. stock ever split?
Tivic Health Systems, Inc.'s last stock split was 1:17 on 2025-03-07.
How did Tivic Health Systems, Inc. perform in the last earnings report?
Revenue: $780,000 | EPS: -$19.67 | Growth: -88.87%.
Where can I find Tivic Health Systems, Inc.'s investor relations reports?
Visit https://www.tivichealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Tivic Health Systems, Inc.?
You can explore historical data from here
What is the all-time high and low for Tivic Health Systems, Inc. stock?
All-time high: $11,050 (2021-11-11) | All-time low: $2.43 (2025-04-01).
What are the key trends affecting Tivic Health Systems, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that key proposals needed to carry out the company's strategic transformation were approved by shareholders at its annual meeting held on June 30, 2025. The approved proposals included the issuance of equity as a form of payment pursuant to Tivic's worldwide exclusive license agreement for Entolimod™ and Entolasta™, including for uses in acute radiation syndrom.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced it has completed all study visits in the Optimization Study for its patent pending, non-invasive cervical vagus nerve stimulation (ncVNS) device. Initial findings reinforce the importance of personalization for therapeutic efficacy. Tivic expects to release the study results later this year.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time | 4:00 PM Eastern Time. The Company has adopted a virtual format for its Annual Meeting to provide a consistent and convenient experience for all stockholders regardless of their location. In lieu of a live Q&A session, stockholders can submit questio.
seekingalpha.com
Tivic Health Systems Inc. (NASDAQ:TIVC ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Lisa Wolf – Interim Chief Financial Officer Michael Handley – Chief Operating Officer and President-Tivic Biopharma Division Conference Call Participants Operator Welcome to Tivic Health Systems First Quarter 2025 Financial Results and Operational Update Conference Call. This call has been prerecorded, and the questions you have submitted in advance will be answered following the prepared remarks.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today it is expanding its non-invasive VNS patent portfolio with the filing of a new patent application with the United States Patent and Trademark Office. Patent No. 63,801,058 entitled “Vagus Nerve Stimulation System” expands the claims and protection around the technology that Tivic is developing and which it expects will redefine state-of-the art in non-invasive vagus.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its first quarter results for 2025 via pre-recorded conference call and webcast on Thursday, May 15, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID: 13753498 Webcast Li.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that it provided briefings to senior leadership at the White House and FDA which garnered significant positive interest in potential military and defense applications for its biologic and bioelectronic product candidates. Both meetings were held in Washington, D.C. on April 17th. The U.S. Government, through agencies including BARDA, NASA, Defense Threats Reduction A.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced that, on March 28, 2025, it exercised its licensing option for the exclusive, worldwide rights to advance Entolimod™ for a second indication, Neutropenia. This expansion of commercial rights is part of the license agreement with Statera Biopharma for its late-stage Toll-like Receptor 5 (TLR5) immunotherapy program Entolimod™. Neutropenia is a condition characterized b.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that it has received confirmation from Nasdaq that the Company has regained compliance with the minimum bid requirements of Nasdaq Listing Rule 5550(a)(2). Consequently, Tivic Health's common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol “TIVC.” About Tivic Health Systems, Inc. Tivic Health is a diversified therapeutics com.
businesswire.com
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its year-end financial results for 2024 via pre-recorded conference call and webcast on Friday, March 21, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID.
See all news
